A phase II study of trilostane for androgen-independent prostate cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Trilostane (Primary) ; Hydrocortisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Dec 2013 Biomarkers information updated
- 09 Feb 2010 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
- 09 Feb 2010 Actual patient number (24) added as reported by ClinicalTrials.gov.